STZ News Alert Constellation Brands Inc (STZ) 113.03 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Constellation Brands Inc (STZ) 113.03 $STZ

'Mad Money' Lightning Round: Buy, Buy, Buy Popeyes Louisiana Kitchen
at The Street - Sat Feb 14, 5:00AM CST
Cramer says Becton Dickinson is one of his favorites while he's a huge fan of Constellation Brands.
BDX: 143.71 (+0.72), SE: 36.81 (+0.61), STZ: 113.03 (-0.48), SAM: 303.26 (-0.97), PLKI: 61.07 (+0.44)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Feb 13, 7:03PM CST
Cramer will be doing a lot of listening to what companies have to say about their business.
ACT: 285.37 (+3.71), BDX: 143.71 (+0.72), SE: 36.81 (+0.61), RRGB: 77.77 (-0.20), CLX: 109.00 (+0.74), WMT: 85.81 (-0.08), STZ: 113.03 (-0.48), SAM: 303.26 (-0.97), PLKI: 61.07 (+0.44), WM: 51.29 (-1.41), PCLN: 1,103.37 (+11.42), FOSL: 98.44 (-0.30), GT: 25.91 (-0.30), COG: 28.10 (+0.18), NVAX: 8.80 (+0.40), DE: 90.04 (+0.67), EOG: 96.92 (+2.12), JWN: 79.41 (+0.04), PG: 85.90 (-0.13), CL: 70.08 (+0.23)

Dividend Growth: Is It Really The Right Strategy For You?
Adam Aloisi - at Seeking Alpha - Fri Feb 13, 5:42PM CST

KO: 41.99 (-0.18), T: 34.66 (+0.05), GILD: 101.90 (+1.10), STZ: 113.03 (-0.48), DIS: 104.17 (+0.59), PG: 85.90 (-0.13), O: 52.01 (+0.32), ARCP: 9.40 (+0.06), GOOG: 549.01 (+6.08), AAPL: 127.08 (+0.62), PCLN: 1,103.37 (+11.42), CSCO: 29.43 (-0.03), NRF: 18.65 (+0.12)

Darling Stocks That Ought to Be Your Valentine - Analyst Blog
Sudipta Mukherjee - Zacks Investment Research - Fri Feb 13, 10:02AM CST
Investors call some stocks their darlings. Date one of these bulls in this season of love.
HSY: 106.02 (-0.64), FB: 75.74 (-0.49), STZ: 113.03 (-0.48), HBI: 119.12 (+1.27), FLWS: 10.33 (-0.02), SIG: 120.19 (+0.36)

Uptrend Call Working As Constellation Brands Stock Rises 29.2% (STZ)
Comtex SmarTrend(R) - Fri Feb 13, 9:40AM CST
SmarTrend identified an Uptrend for Constellation Brands (NYSE:STZ) on October 23rd, 2014 at $87.45. In approximately 4 months, Constellation Brands has returned 29.22% as of today's recent price of $113.00.
STZ: 113.03 (-0.48)

Technical Notes Covering Beverages Equities - Ambev, Anheuser-Busch InBev, Dr. Pepper Snapple, Constellation Brands, and Molson Coors Brewing
PR Newswire - Fri Feb 13, 7:35AM CST
Editor Note: For more information about this release, please scroll to bottom.
DPS: 76.95 (-1.35), BUD: 121.72 (-0.80), ABEV: 6.37 (-0.07), TAP: 72.82 (-0.96), STZ: 113.03 (-0.48)

Dean Foods Falls on Dismal Q4 Earnings & Cautious '15 View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:15AM CST
Shares of Dean Foods Company (DF) plunged 11.9% yesterday, after the company posted dismal fourth-quarter and 2014 earnings and provided a cautious outlook for 2015 due to uncertain industry dynamics.
SVU: 10.21 (+0.04), SAM: 303.26 (-0.97), STZ: 113.03 (-0.48), DF: 16.19 (-0.11)

Molson Coors Lags Q4 Earnings, Revenues on Low Volumes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 1:01PM CST
Global brewer Molson Coors Brewing Company (TAP) delivered lower-than-expected earnings in the fourth quarter and full-year 2014.
DPS: 76.95 (-1.35), SAM: 303.26 (-0.97), STZ: 113.03 (-0.48), TAP: 72.82 (-0.96)

Constellation Brands' Valuation Suggests Unrealistic Expectations
Josh Arnold - at Seeking Alpha - Sat Feb 07, 2:17PM CST

STZ: 113.03 (-0.48)

Look Beyond January's Stock Market Slump and Buy These Sectors
at The Street - Fri Feb 06, 5:20AM CST
Buy the S&P 500 sectors that performed best this January and hold them for at least a year.
HAR: 136.40 (-3.18), KR: 72.86 (+0.41), EA: 56.39 (+0.20), BXP: 141.08 (-1.58), NEM: 24.78 (+0.27), AIV: 38.55 (-0.50), STZ: 113.03 (-0.48), XLU: 45.17 (-0.70), VTR: 76.61 (-0.41), XLV: 70.72 (+0.28), XLP: 49.50 (-0.23), KIM: 26.83 (-0.25), SPY: 209.78 (+0.86), EXPE: 89.49 (-0.08)

NYSE stocks posting largest volume decreases
AP - Tue Feb 03, 5:44PM CST
NEW YORK (AP) — A look at the 10 biggest volume decliners on New York Stock Exchange at the close of trading:
BRT: 6.98 (-0.02), TCI: 10.67 (-0.13), FCE.A: 25.32 (-0.08), STZ: 113.03 (-0.48), ARL: 5.65 (+0.14), STZ.B: 112.58 (-0.82), NTL: 22.97 (+0.84)

Owens-Illinois Q4 Earnings in Line; Provides 2015 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 9:15AM CST
Owens-Illinois' (OI) fourth-quarter earnings were in line with the Zacks Consensus Estimate.
ADEP: 6.93 (-0.30), OI: 26.36 (+0.46), STZ: 113.03 (-0.48), ABGB: 15.52 (+0.34)

Diageo's 2H14 Earnings on Unfavorable Fx - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 7:50AM CST
Diageo plc's (DEO) second half of 2014 earnings in the second half of 2014 (ended Dec 31) went down 16.6% y/y to 53.7 pence (87.4 cents* per share) from 62.6 pence (99.2 cents** per share).
SVU: 10.21 (+0.04), SAM: 303.26 (-0.97), STZ: 113.03 (-0.48), DEO: 113.89 (-1.40)

Constellation Brands Up 27.8% Since SmarTrend Uptrend Call (STZ)
Comtex SmarTrend(R) - Thu Jan 29, 4:55PM CST
SmarTrend identified an Uptrend for Constellation Brands (NYSE:STZ) on October 23rd, 2014 at $87.45. In approximately 3 months, Constellation Brands has returned 27.82% as of today's recent price of $111.78.
STZ: 113.03 (-0.48)

Constellation Brands: Huge Charges Loom For 2015 That Analysts Don't Seem To See Coming
The Specialist - at Seeking Alpha - Tue Jan 27, 4:20AM CST

STZ: 113.03 (-0.48)

Forget Marijuana Stocks: Here Are 3 Smarter Investments
Motley Fool Staff - Motley Fool - Sat Jan 24, 3:01PM CST
Marijuana stocks were among last year's top performers, but that doesn't guarantee that they'll be top stocks this year, too. Although the allure of marijuana's potential from legalization may be enticing, investors could discover that these three...
RAI: 71.86 (-1.23), PM: 82.87 (-0.82), BUD: 121.72 (-0.80), BMRN: 100.76 (+1.98), LO: 67.30 (-0.80), STZ: 113.03 (-0.48), MO: 54.76 (-0.78), BMY: 60.04 (+0.56)

'Mad Money' Lightning Round: Constellation Brands the New King in Town
at The Street - Sat Jan 24, 5:00AM CST
Cramer likes BioMarin over Juno Therapeutics, Cypress Semiconductor over Micron Technology and Take-Two Interactive over Zynga.
BIIB: 391.66 (-0.45), CY: 14.76 (+0.01), MU: 31.85 (-0.09), CLR: 47.36 (+0.74), BMRN: 100.76 (+1.98), STZ: 113.03 (-0.48), CELG: 115.88 (+0.16), TTWO: 28.40 (+0.96), RDS.A: 66.32 (+0.97), NAP: 13.75 (-0.24), JUNO: 40.52 (+0.18), ZNGA: 2.24 (-0.42), BF.B: 90.72 (-0.28), Z: 106.50 (+1.75), TNK: 5.50 (+0.10)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Scorpius Holdings Boosts Efficiency with New Cost Reduction Plan

Updated Category News Views 183

Scorpius Holdings Implements Significant Cost-Saving Strategies Scorpius Holdings, Inc. (NYSE American: SCPX), a notable player in the biomanufacturing landscape, has recently introduced a series of strategic cost-saving measures. These initiatives aim to reduce operational costs by more than $2 million annually, showcasing the company's commitment to enhancing its...

Continue Reading
McKesson's Strategic Shift: Selling Rexall and Well.ca

Updated Category News Views 122

McKesson Corporation Expands Focus on Healthcare Services IRVING, Texas - McKesson Corporation (NYSE: MCK), a leader in healthcare services with a market capitalization of $72.45 billion and annual revenue exceeding $330 billion, has officially completed the sale of its Rexall and Well.ca businesses to Birch Hill Equity Partners. This noteworthy decision allows McKesson...

Continue Reading
GSI Group Enhances Market with GenesisBPS Acquisition

Updated Category News Views 155

GSI Group Strengthens Its Portfolio GSI Group Holdings has made a significant move by acquiring GenesisBPS, an innovative designer and manufacturer of specialized benchtop blood processing equipment and laboratory consumables. This acquisition enhances GSI Group's expanding global sales platform, reinforcing its commitment to serving the life sciences, research and...

Continue Reading
Forecasting Growth in the Antidepressant Drugs Market

Updated Category News Views 156

Understanding the Antidepressant Drugs Market The Antidepressant Drugs Market is anticipated to undergo significant growth, with a projection to reach USD 26.9 billion by 2033. This upward trend reflects a compound annual growth rate (CAGR) of 3.3% from 2024 to 2033, highlighting the increasing reliance on these medications to treat depression. Antidepressants are...

Continue Reading
Inceptio Technology Introduces Strategic Vision for L4 Trucks

Updated Category News Views 227

A Visionary Approach to L4 Autonomous Trucking by Inceptio Technology Inceptio Technology is making significant strides in the field of autonomous trucking, sharing its detailed strategy for scaling Level 4 (L4) autonomous trucks. The company recently took center stage at the Next Truck 2025 conference, demonstrating its commitment to reshaping the future of...

Continue Reading